Boehringer makes significant investment to improve the affordability of and access to its full range of inhaler products for COPD and asthma Expansive program builds on the company’s century-long commitment to patients with respiratory illnesses RIDGEFIELD, Conn., March 7, 2024…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.